第一作者:
Ruhina S,Laskar
第一单位:
International Agency for Research on Cancer (IARC), Lyon, France.
作者:
Ruhina S,Laskar [1]
;
David C,Muller [2]
;
Peng,Li [3]
;
Mitchell J,Machiela [4]
;
Yuanqing,Ye [5]
;
Valerie,Gaborieau [1]
;
Matthieu,Foll [1]
;
Jonathan N,Hofmann [4]
;
Leandro,Colli [4]
;
Joshua N,Sampson [4]
;
Zhaoming,Wang [6]
;
Delphine,Bacq-Daian [7]
;
Anne,Boland [7]
;
Behnoush,Abedi-Ardekani [1]
;
Geoffroy,Durand [1]
;
Florence,Le Calvez-Kelm [1]
;
Nivonirina,Robinot [1]
;
Helene,Blanche [8]
;
Egor,Prokhortchouk [9]
;
Konstantin G,Skryabin [9]
;
Laurie,Burdett [4]
;
Meredith,Yeager [4]
;
Sanja,Radojevic-Skodric [10]
;
Slavisa,Savic [11]
;
Lenka,Foretova [12]
;
Ivana,Holcatova [13]
;
Vladimir,Janout [14]
;
Dana,Mates [15]
;
Stefan,Rascu [16]
;
Anush,Mukeria [17]
;
David,Zaridze [17]
;
Vladimir,Bencko [18]
;
Cezary,Cybulski [19]
;
Eleonora,Fabianova [20]
;
Viorel,Jinga [16]
;
Jolanta,Lissowska [21]
;
Jan,Lubinski [19]
;
Marie,Navratilova [12]
;
Peter,Rudnai [22]
;
Beata,Świątkowska [23]
;
Simone,Benhamou [24]
;
Geraldine,Cancel-Tassin [25]
;
Olivier,Cussenot [25]
;
Antonia,Trichopoulou [26]
;
Elio,Riboli [2]
;
Kim,Overvad [27]
;
Salvatore,Panico [28]
;
Borje,Ljungberg [29]
;
Raviprakash T,Sitaram [29]
;
Graham G,Giles [30]
;
Roger L,Milne [30]
;
Gianluca,Severi [31]
;
Fiona,Bruinsma [32]
;
Tony,Fletcher [33]
;
Kvetoslava,Koppova [20]
;
Susanna C,Larsson [34]
;
Alicja,Wolk [34]
;
Rosamonde E,Banks [35]
;
Peter J,Selby [35]
;
Douglas F,Easton [36]
;
Paul,Pharoah [36]
;
Gabriella,Andreotti [4]
;
Laura E,Beane Freeman [4]
;
Stella,Koutros [4]
;
Demetrius,Albanes [4]
;
Satu,Männistö [37]
;
Stephanie,Weinstein [4]
;
Peter E,Clark [38]
;
Todd L,Edwards [38]
;
Loren,Lipworth [38]
;
Hallie,Carol [39]
;
Matthew L,Freedman [39]
;
Mark M,Pomerantz [39]
;
Eunyoung,Cho [40]
;
Peter,Kraft [41]
;
Mark A,Preston [42]
;
Kathryn M,Wilson [41]
;
J,Michael Gaziano [42]
;
Howard D,Sesso [41]
;
Amanda,Black [4]
;
Neal D,Freedman [4]
;
Wen-Yi,Huang [4]
;
John G,Anema [43]
;
Richard J,Kahnoski [43]
;
Brian R,Lane [44]
;
Sabrina L,Noyes [45]
;
David,Petillo [45]
;
Bin Tean,Teh [45]
;
Ulrike,Peters [46]
;
Emily,White [46]
;
Garnet L,Anderson [47]
;
Lisa,Johnson [47]
;
Juhua,Luo [48]
;
Wong-Ho,Chow [5]
;
Lee E,Moore [4]
;
Toni K,Choueiri [39]
;
Christopher,Wood [5]
;
Mattias,Johansson [1]
;
James D,McKay [1]
;
Kevin M,Brown [4]
;
Nathaniel,Rothman [4]
;
Mark G,Lathrop [49]
;
Jean-Francois,Deleuze [50]
;
Xifeng,Wu [5]
;
Paul,Brennan [1]
;
Stephen J,Chanock [4]
;
Mark P,Purdue [4]
;
Ghislaine,Scelo [51]
作者单位:
International Agency for Research on Cancer (IARC), Lyon, France.
[1]
Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
[2]
Max Planck Institute for Demographic Research, Rostock, Germany.
[3]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
[4]
Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[5]
Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
[6]
Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.
[7]
Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
[8]
Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation.;Kurchatov Scientific Center, Moscow, Russian Federation.
[9]
Institute of Pathology, Medical school of Belgrade, Belgrade, Serbia.
[10]
Department of Urology, University Hospital "Dr D. Misovic" Clinical Center, Belgrade, Serbia.
[11]
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
[12]
2nd Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.
[13]
Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.;Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
[14]
National Institute of Public Health, Bucharest, Romania.
[15]
Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
[16]
Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
[17]
First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
[18]
International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
[19]
Regional Authority of Public Health in BanskaBystrica, BanskaBystrica, Slovakia.
[20]
The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
[21]
National Public Health Institute, Budapest, Hungary.
[22]
Department of Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.
[23]
INSERM U946, Paris, France.;CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
[24]
Sorbonne Université, GRC no. 5, ONCOTYPE-URO, AP-HP, Tenon Hospital, Paris, France.;CeRePP, Paris, France.
[25]
Hellenic Health Foundation, Alexandroupoleos 23, Athens, 11527, Greece.
[26]
Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus C, Denmark.
[27]
Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
[28]
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
[29]
Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville Victoria, 3010, Australia.
[30]
Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.;Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Facultés de Medicine, Université Paris-Saclay, Université Paris-Sud, UVSQ, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France.
[31]
Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.
[32]
London School of Hygiene and Tropical Medicine, University of London, London, UK.
[33]
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
[34]
Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
[35]
Department of Oncology, University of Cambridge, Cambridge, UK.;Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[36]
National Institute for Health and Welfare, Helsinki, Finland.
[37]
Vanderbilt-Ingram Cancer Center, Nasville, TN, USA.
[38]
Dana-Farber Cancer Institute, Bostan, MA, USA.
[39]
Brown University, Providence, RI, USA.
[40]
Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[41]
Brigham and Women's Hospital and VA Boston, Boston, MA, USA.
[42]
Division of Urology, Spectrum Health, Grand Rapids, MI, USA.
[43]
Division of Urology, Spectrum Health, Grand Rapids, MI, USA.;College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
[44]
Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
[45]
Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[46]
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[47]
Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA.
[48]
McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.
[49]
Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.;Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
[50]
International Agency for Research on Cancer (IARC), Lyon, France. scelog@iarc.fr.
[51]
医学主题词
癌, 肾细胞(Carcinoma, Renal Cell);计算生物学(Computational Biology);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);全基因组关联研究(Genome-Wide Association Study);人类(Humans);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);比值比(Odds Ratio);多态性, 单核苷酸(Polymorphism, Single Nucleotide);数量性状基因座位(Quantitative Trait Loci);性别因素(Sex Factors)
DOI
10.1038/s41431-019-0455-9
PMID
31231134
发布时间
2025-05-30
- 浏览1
European journal of human genetics
European journal of human genetics
1589-1598页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



